Cargando…

A 16-Month Community-Based Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease

INTRODUCTION: Cardiovascular diseases are the leading causes of disability and death in the United States. Primary prevention of these events may be achieved through aspirin use. The ability of a community-based intervention to increase aspirin use has not been evaluated. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oldenburg, Niki C., Duval, Sue, Luepker, Russell V., Finnegan, John R., LaMarre, Heather, Peterson, Kevin A., Zantek, Nicole D., Jacobs, Ginny, Straka, Robert J., Miller, Karen H., Hirsch, Alan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023687/ https://www.ncbi.nlm.nih.gov/pubmed/24831287 http://dx.doi.org/10.5888/pcd11.130378

Ejemplares similares

Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey
por: Luepker, Russell V., et al.
Publicado: (2015)

Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease: A Nonrandomized Controlled Trial
por: Luepker, Russell V., et al.
Publicado: (2022)

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
por: Michaud, Tzeyu L., et al.
Publicado: (2015)

News coverage and online advertising effects on patient-led search for aspirin, heart health, and stroke information and educational tool use
por: Southwell, Brian G., et al.
Publicado: (2021)

Use of a Geographic Information System to create treatment groups for group-randomized community trials: The Minnesota Heart Health Program
por: Krzyzanowski, Brittany, et al.
Publicado: (2019)

Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007—2015: A Serial, Cross‐sectional Study
por: Van't Hof, Jeremy R., et al.
Publicado: (2017)

The FReedom from Ischemic Events - New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease
por: Keo, Hong H, et al.
Publicado: (2013)

Estimation of Cardiovascular Risk from Self-Reported Knowledge of Risk Factors: Insights from the Minnesota Heart Survey
por: Duval, Sue, et al.
Publicado: (2020)

Promoting Aspirin Use for Cardiovascular Disease Prevention Among an Adult Internet-Using Population: A Pilot Study
por: Oldenburg, Niki C., et al.
Publicado: (2021)

Satire without borders: the age-moderated effect of one-sided versus two-sided satire on hedonic experiences and patriotism
por: Boukes, Mark, et al.
Publicado: (2023)

The Incidence and Health Economic Burden of Ischemic Amputation in Minnesota, 2005-2008
por: Peacock, James M., et al.
Publicado: (2011)

Low Serum Glutathione Peroxidase Activity Is Associated with Increased Cardiovascular Mortality in Individuals with Low HDLc’s
por: Buijsse, Brian, et al.
Publicado: (2012)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Barriers to Infectious Disease Prevention among Women
por: Thierry, JoAnn, et al.
Publicado: (2004)

MicroRNAs: potential targets and agents of endocrine disruption in female reproduction
por: Sabry, Reem, et al.
Publicado: (2019)

RF22 | PMON08 The effects of Bisphenol A on miR-21 expression and miR-21 mediated apoptosis in bovine granulosa cells.
por: Sabry, Reem, et al.
Publicado: (2022)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Platelets, Aspirin and Cardiovascular Disease
por: Elwood, P. C.
Publicado: (1976)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
por: Bem, Danai, et al.
Publicado: (2015)

Characteristics of miRNAs Present in Bovine Sperm and Associations With Differences in Fertility
por: Werry, Nicholas, et al.
Publicado: (2022)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

An open invitation to productive conversations about feminism and the spectrum of eating disorders (part 1): basic principles of feminist approaches
por: LaMarre, Andrea, et al.
Publicado: (2022)

An open invitation to productive conversations about feminism and the spectrum of eating disorders (part 2): Potential contributions to the science of diagnosis, treatment, and prevention
por: LaMarre, Andrea, et al.
Publicado: (2022)

Twenty‐Two‐Year Population Trends in Sodium and Potassium Consumption: The Minnesota Heart Survey
por: Meyer, Katie A., et al.
Publicado: (2013)

cDNA Cloning of Feline PIWIL1 and Evaluation of Expression in the Testis of the Domestic Cat
por: Stalker, Leanne, et al.
Publicado: (2023)

Conceptualizing eating disorder recovery research: Current perspectives and future research directions
por: Hower, Heather, et al.
Publicado: (2022)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

An observational study of a clinical guideline implementation project in primary care
por: Eder, Milton “Mickey”, et al.
Publicado: (2019)

MicroRNA Expression during Bovine Oocyte Maturation and Fertilization
por: Gilchrist, Graham C., et al.
Publicado: (2016)

BPA Decreases PDCD4 in Bovine Granulosa Cells Independently of miR-21 Inhibition
por: Sabry, Reem, et al.
Publicado: (2022)

Investigating the role of early low-dose aspirin in diabetes: A phase III multicentre double-blinded placebo-controlled randomised trial of aspirin therapy initiated in the first trimester of diabetes pregnancy
por: Finnegan, Catherine, et al.
Publicado: (2019)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
por: Zhao, Yixi, et al.
Publicado: (2021)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
por: Coccheri, Sergio
Publicado: (2017)

Aspirin in the Modern Era of Cardiovascular Disease Prevention
por: Murphy, Ella, et al.
Publicado: (2021)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

MicroRNA-34 family expression in bovine gametes and preimplantation embryos
por: Tscherner, Allison, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hg78s0i2hr9dkmplnvct6s33ks